Royal Bank Of Canada Kymera Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 5,775 shares of KYMR stock, worth $240,182. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,775

Previous 4,184 38.03%

Holding current value

$240,182

Previous $124,000 120.16%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.16 - $52.4 $47,984 - $83,368	1,591 Added 38.03%	5,775 $273,000
Q2 2024 Aug 14, 2024	BUY	$29.85 - $39.42 $90,982 - $120,152	3,048 Added 268.31%	4,184 $124,000
Q1 2024 Nov 05, 2024	SELL	$22.9 - $43.57 $69,799 - $132,801	-3,048 Reduced 72.85%	1,136 $45,000
Q1 2024 May 15, 2024	SELL	$22.9 - $43.57 $245,442 - $466,983	-10,718 Reduced 90.42%	1,136 $45,000
Q4 2023 Feb 14, 2024	BUY	$10.97 - $26.84 $77,843 - $190,456	7,096 Added 149.14%	11,854 $301,000
Q3 2023 Nov 14, 2023	BUY	$13.9 - $23.88 $27,591 - $47,401	1,985 Added 71.58%	4,758 $66,000
Q2 2023 Aug 14, 2023	BUY	$22.4 - $34.92 $14,336 - $22,348	640 Added 30.0%	2,773 $63,000
Q1 2023 May 15, 2023	SELL	$24.84 - $38.75 $82,021 - $127,952	-3,302 Reduced 60.75%	2,133 $63,000
Q4 2022 Feb 14, 2023	BUY	$19.57 - $30.92 $97,360 - $153,827	4,975 Added 1081.52%	5,435 $135,000
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $5,164 - $8,464	247 Added 115.96%	460 $10,000
Q2 2022 Aug 15, 2022	SELL	$14.13 - $42.55 $27,256 - $82,078	-1,929 Reduced 90.06%	213 $4,000
Q1 2022 May 16, 2022	SELL	$35.3 - $64.68 $196,726 - $360,461	-5,573 Reduced 72.24%	2,142 $90,000
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $207,525 - $272,598	4,158 Added 116.9%	7,715 $490,000
Q3 2021 Nov 15, 2021	SELL	$47.8 - $66.66 $73,612 - $102,656	-1,540 Reduced 30.21%	3,557 $209,000
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $158,414 - $264,789	5,097 New	5,097 $247,000

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.28B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Kymera Therapeutics, Inc. Transaction History